Saladax is Advancing Personalized Therapeutic Drug Monitoring for Chemotherapy

Bethlehem, PA – October 13, 2016 – Saladax Biomedical Inc., a provider of immunoassays for oncology, today unveiled its new company website at Saladax.com. With updated functionality and a new look and feel, Saladax Biomedical's website now features enhanced search capabilities, progressive user interface, and easily accessible information for oncologists, pathologists, researchers, laboratorians, distributors and patients. Saladax Biomedical stands at the forefront of therapeutic drug monitoring (TDM) in oncology. The new website offers great resources to support TDM.

“Saladax continues to look for ways to advance personalized medicine,” said Saladax CEO, Salvatore Salamone. “We hope our new website will provide a valuable resource for oncologists and patients to better understand the benefits of the right drug and the right dose. We will not fully achieve the promise of personalized medicine unless we are able to dose the drug properly.”

In addition to the updated website, Saladax recently expanded its contract research and companion diagnostics (CDx) capabilities. Saladax is well known for its ability to efficiently develop quality companion diagnostics for important pharmaceutical partners. Companion diagnostics advance and promote personalized healthcare by guiding therapy, predicting which patients are most likely to benefit from a particular therapy or which therapy could best be administered to an individual. The healthcare industry understands the wider benefits of a companion diagnostics test in delivering reduced healthcare costs and improved patient outcomes.

About Saladax

Founded in 2004, Saladax Biomedical, Inc. is a privately held company headquartered as an anchor tenant with Ben Franklin TechVentures® and client of the Ben Franklin Technology Partners of Northeastern Pennsylvania on Lehigh University’s campus in Bethlehem, PA. Saladax develops novel blood tests to increase the impact of personalized medicine by bringing chemotherapeutic drug monitoring to oncologists. Saladax believes that truly personalized medicine can only exist when the right drug is given at the right dose. Our diagnostic reagents and kits are distributed worldwide excluding the United States. Saladax is ISO 13485:2003 certified. For more information, visit www.Saladax.com.